Intravitreal Bevacizumab for Posterior Capsule Neovascularization
Overview
Affiliations
We report a case of rapid regression of extensive posterior capsule neovascularization in a 67-year-old diabetic male patient, who developed posterior capsule opacity with neovascularization one year post cataract surgery, after a single injection of intravitreal bevacizumab (Avastin) followed by neodymium:YAG capsulotomy. Rapid regression of the posterior capsule neovascularization, and visual improvement was observed 9 days after the intervention. Posterior capsulotomy was performed successfully without bleeding. Prior to posterior capsulotomy, intravitreal bevacizumab can result in rapid and dramatic regression of posterior capsule neovascularization.
Posterior lens capsule neovascularization treated with anti-VEGF complicated by phacogenic uveitis.
Tai F, Mandelcorn E, Somani S Am J Ophthalmol Case Rep. 2020; 20:100943.
PMID: 33204896 PMC: 7652777. DOI: 10.1016/j.ajoc.2020.100943.